MYCN and neuroblastoma: MYCNOS18 and IGF2BP116 promote MYCN-driven neuroblastoma metastasis and tumorigenesis, respectively, RNF21727, GRIK328, and SLCO5A129 promotes leukemia, breast and colon cancer.